Competitors for slendering medications triggers Lars Rebien Sørensen to attract parallels with the cost battles that formerly struck Novo Nordisk hard.
发布者:BY ANJA HAUGE,转转请注明出处:https://robotalks.cn/novo-nordisk-chairman-warns-of-repeat-insulin-price-war-in-obesity-business/